IGF2 and acute myeloid leukemia: Upregulation of IGF2 in solid tumors is well documented in a variety of cancers, including colorectal [66], ovarian [67], esophageal [68] cancers, and in acute myeloid leukemia [69], and TCGA analysis shows that IGF2 is also overexpressed in HNC versus normal tissue (Figure S6).